McKenzie Mathurin and Macy Marriccini are Broken Arrow's representatives. Fort Gibson's two players are Laynee Stanley and Addy Whiteley ...

Notre Dame-Green Pond softball player Hannah Lilly and Emmaus boys track and field athlete Jared Petre are our Athlete of the Week winners for Week 30 of the 2024-25 season. Hannah Lilly ...

The chatbot's latest feature builds on that foundation and could even make it a more effective personal assistant. Also: Canva just dropped 6 exciting AI features in its biggest update in years On ...

Entrepreneur Weihong Liu is the board chairwoman of Central Walk, a retail investment company that owns three shopping centres in B.C. Liu has shared a series of videos on the Chinese ...

Amazon made it clear that while it will have the details of orders initiated through its app, it will not have access to a customer’s previous shopping history with a brand, nor any details of future ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares closed yesterday at $726.24.

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock is, again, testing multiyear lows. The $700 billion pharmaceutical giant ...

According to Google, this feature can serve as a creative partner, a shopping assistant, an organizer and more. As a creative partner, Google explains that Gemini Live can help you generate ideas ...

INDIANAPOLIS — Eli Lilly and Company says it's suing an Indianapolis-based weight loss clinic that it claims is misleading patients about drugs being sold. Lilly claims Premier Weight Loss is selling ...

In 2024 alone, the bank’s AI-powered assistant, Fargo, handled 245.4 million interactions – more than doubling its original projections – and it did so without ever exposing sensitive ...

I argue that the company that owns the AI assistant consumers trust to handle their shopping will dominate retail's future. "Buy For Me" represents another strategic move in this battle.

Eli Lilly and Sangamo Therapeutics have entered into a licensing agreement worth over $1.4bn to deliver genomic medicines for central nervous system (CNS) diseases. The deal gives Lilly an exclusive ...